ArticleWiener klinische Wochenschrift2016

Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?

Adnan Incebiyik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.